Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification

R Kamps, RD Brandão, BJ van den Bosch… - International journal of …, 2017 - mdpi.com
Next-generation sequencing (NGS) technology has expanded in the last decades with
significant improvements in the reliability, sequencing chemistry, pipeline analyses, data …

Next-generation sequencing: advances and applications in cancer diagnosis

S Serratì, S De Summa, B Pilato, D Petriella… - OncoTargets and …, 2016 - Taylor & Francis
Technological advances have led to the introduction of next-generation sequencing (NGS)
platforms in cancer investigation. NGS allows massive parallel sequencing that affords …

Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of …

NI Lindeman, PT Cagle, DL Aisner… - … of pathology & …, 2018 - meridian.allenpress.com
Context.—In 2013, an evidence-based guideline was published by the College of American
Pathologists, the International Association for the Study of Lung Cancer, and the Association …

Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas

E Amato, M Molin, A Mafficini, J Yu… - The Journal of …, 2014 - Wiley Online Library
Intraductal neoplasms are important precursors to invasive pancreatic cancer and provide
an opportunity to detect and treat pancreatic neoplasia before an invasive carcinoma …

[HTML][HTML] Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups

M Simbolo, M Fassan, A Ruzzenente, A Mafficini… - Oncotarget, 2014 - ncbi.nlm.nih.gov
One-hundred-fifty-three biliary cancers, including 70 intrahepatic cholangiocarcinomas
(ICC), 57 extrahepatic cholangiocarcinomas (ECC) and 26 gallbladder carcinomas (GBC) …

MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer

R Cui, W Meng, HL Sun, T Kim, Z Ye… - Proceedings of the …, 2015 - National Acad Sciences
Lung cancer is the leading cause of cancer-related deaths worldwide. Despite
advancements and improvements in surgical and medical treatments, the survival rate of …

Preanalytic variables in cytology: lessons learned from next-generation sequencing—the MD Anderson experience

S Roy-Chowdhuri, J Stewart - Archives of pathology & …, 2016 - meridian.allenpress.com
Context.—As our understanding of genomic alterations underlying solid tumor malignancies
continues to evolve, molecular testing of tumor samples is increasingly used to guide …

Expert opinion on NSCLC small specimen biomarker testing—Part 2: Analysis, reporting, and quality assessment

F Penault-Llorca, KM Kerr, P Garrido, E Thunnissen… - Virchows Archiv, 2022 - Springer
The diagnostic work-up for non-small cell lung cancer (NSCLC) requires biomarker testing
to guide therapy choices. This article is the second of a two-part series. In Part 1, we …

Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components

M Scardoni, E Vittoria, M Volante, B Rusev… - …, 2015 - karger.com
Background: Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal
tract are rare neoplasms characterized by coexisting exocrine and neuroendocrine …

Biomarker testing in lung carcinoma cytology specimens: a perspective from members of the Pulmonary Pathology Society

S Roy-Chowdhuri, DL Aisner… - … of pathology & …, 2016 - meridian.allenpress.com
The advent of targeted therapy in lung cancer has heralded a paradigm shift in the practice
of cytopathology with the need for accurately subtyping lung carcinoma, as well as providing …